| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
FibroGen Inc (NASDAQ: FGEN)
FGEN Technical Analysis
5
| As on 9th Jun 2023 FGEN STOCK Price closed @ 16.98 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 12.99 & Strong Buy for SHORT-TERM with Stoploss of 14.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FGENSTOCK Price
| Open | 17.72 | Change | Price | % |
| High | 17.73 | 1 Day | -0.80 | -4.50 |
| Low | 15.61 | 1 Week | -0.27 | -1.57 |
| Close | 16.98 | 1 Month | 0.27 | 1.62 |
| Volume | 1787600 | 1 Year | 2.34 | 15.98 |
| 52 Week High 25.18 | 52 Week Low 7.94 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FGEN Daily Charts |
FGEN Intraday Charts |
Whats New @ Bazaartrend |
FGEN Free Analysis |
|
|
FGEN Important Levels Intraday
| RESISTANCE | 21.07 |
| RESISTANCE | 19.76 |
| RESISTANCE | 18.95 |
| RESISTANCE | 18.14 |
| SUPPORT | 15.82 |
| SUPPORT | 15.01 |
| SUPPORT | 14.20 |
| SUPPORT | 12.89 |
FGEN Forecast May 2024
| 4th UP Forecast | 24.32 |
| 3rd UP Forecast | 21.97 |
| 2nd UP Forecast | 20.51 |
| 1st UP Forecast | 19.06 |
| 1st DOWN Forecast | 14.9 |
| 2nd DOWN Forecast | 13.45 |
| 3rd DOWN Forecast | 11.99 |
| 4th DOWN Forecast | 9.64 |
FGEN Weekly Forecast
| 4th UP Forecast | 19.58 |
| 3rd UP Forecast | 18.75 |
| 2nd UP Forecast | 18.23 |
| 1st UP Forecast | 17.72 |
| 1st DOWN Forecast | 16.24 |
| 2nd DOWN Forecast | 15.73 |
| 3rd DOWN Forecast | 15.21 |
| 4th DOWN Forecast | 14.38 |
FGEN Forecast2024
| 4th UP Forecast | 51.43 |
| 3rd UP Forecast | 40.38 |
| 2nd UP Forecast | 33.55 |
| 1st UP Forecast | 26.72 |
| 1st DOWN Forecast | 7.24 |
| 2nd DOWN Forecast | 0.41 |
| 3rd DOWN Forecast | -6.42 |
| 4th DOWN Forecast | -17.47 |
FibroGen Inc ( NASDAQ USA Symbol : FGEN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FGEN Business Profile
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States and Europe; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase II trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California. Address: 409 Illinois Street, San Francisco, CA, United States, 94158
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service